NFX BIO
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach. Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massive implications.
NFX BIO
Industry:
Biotechnology Financial Services Impact Investing Information Technology
Founded:
2021-01-01
Status:
Active
Similar Organizations
Tahoma Ventures
Tahoma Ventures provides early stage capital to IT technology startups.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-02 | Eleven Therapeutics | NFX Bio investment in Seed Round - Eleven Therapeutics | 22 M USD |
| 2021-06-06 | Pangea Therapeutics Ltd. | NFX Bio investment in Seed Round - Pangea Therapeutics Ltd. | N/A |
More informations about "NFX Bio"
NFX - Bio
Still today, Scientists are typically not empowered to run companies. Instead, they are replaced by people with business experience, retaining minimal equity. We believe the best Founders are Scientist-Founders. We help scientists learn to be Founders and have found it works far better than the other way around. See moreSee details»
Launching NFX Bio and The Rise of the Scientist Founder
NFX Bio is here to fund Scientist-Founders and support them in learning how to be entrepreneurs. We bring the full power of a large platform venture capital firm to pre-seed and seed-stage bio startups. We’ve been Scientist-Founders …See details»
NFX - NFX Bio Companies
We join forces with rare individuals who make the whole of our network greater than the sum of its parts. We refuse to think of our founders as a “portfolio” – instead, we’re cultivating a Guild.See details»
NFX Bio - Crunchbase Investor Profile & Investments
NFX Bio invests in seed to early-stage biotechnology and medical companies, focusing on therapeutics. Their investment strategy spans North America and Asia, with key locations in …See details»
New Synthetic Biology Venture Fund Puts ‘Scientist Founders’ First
Feb 2, 2021 · Announced today, this initiative will be led by new NfX partner, Omri Amirav Drory, Ph.D., and advised by Twist co-founder and CEO, Emily Leproust, Ph.D. This won’t be the first …See details»
NFX Bio: Investing in Scientist-Founders from the Very ... - YouTube
Dec 13, 2021 · we started NFX Bio as a home for Scientist-Founders working at the intersection of tech and bio to solve humanity's biggest challenges. ...more. You might think a self-driving …See details»
NFX Bio - Investments, Portfolio & Company Exits - Crunchbase
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.See details»
10 Questions w/ Omri Amirav-Drory— General Partner …
Sep 14, 2022 · Omri Amirav-Drory, Ph.D. is the General Partner at NFX Bio. He is a scientist and an operator who has founded, scaled, and invested in some of today’s most important techbio companies....See details»
NfX Bio Portfolio Investments, NfX Bio Funds, NfX Bio Exits - CB …
NFX Bio is a venture capital firm focused on funding and supporting scientist-founders in the biotechnology and tech-bio startup sectors. Use the CB Insights Platform to explore NfX Bio's …See details»
NFX - Our Philosophy
NFX Bio is the home for Scientist-Founders. We have been in your shoes, and have, ourselves, invented new approaches to biology and started and scaled these companies to multi-billion …See details»
NFX Bio - Contacts, Employees, Board Members, Advisors & Alumni
NFX Bio has 5 current employee profiles, including Venture Partner Omri Amirav-Drory. NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology …See details»
The Crowdsourced History of Techbio
At the beginning is the core truth of techbio: once you see biology as code, it unlocks more applications than you could ever imagine. We are only getting started.See details»
New Synthetic Biology Venture Fund Puts ‘Scientist Founders’ First
Feb 8, 2021 · One of the key funding trends in 2020 was the record level interest of venture firms in the biotech space. As SynBioBeta’s report projected, this trend is continuing into 2021 with …See details»
Anastasia Budinskaya - Bio Associate at NFX - The Org
Anastasia Budinskaya is an accomplished professional with extensive experience in the biotech sector, currently serving as an Investor at NFX and Co-Founder & Chief Business Officer at …See details»
The NFX Podcast
NFXBio: The Promise of Synthetic Embryos with Dr. Jacob Hanna of Renewal Bio Episode Summary. We're highlighting a breakthrough moment - this summer, Dr. Jacob Hanna, a …See details»
Top November 2024 Resources for Bio Founders - NFX Library
Weekly insights for pre-seed and seed stage Founders in Bio, including fundraising tips, pitch decks, growth, hiring and more.See details»
Seed Round - resistanceBio - 2022-07-04 - Crunchbase
Jul 4, 2022 · NFX Bio NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.See details»
Bio Companies - NFX
We join forces with rare individuals who make the whole of our network greater than the sum of its parts.See details»
NFX Bio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.See details»
Meet the 2025 NFX Fellows
Introducing the 2025 NFX fellows. These fellows were chosen from 300+ applications for their expertise in tech, operations, and investing.See details»